- Title
- Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
- Creators - without role
- Yu Ri Kim - Yonsei UniversityJin Seok Kim - Yonsei UniversityYoo Hong Min - Yonsei UniversityDok Hyun Yoon - Chonnam National University Hwasun HospitalHo-Jin Shin - Pusan National University HospitalYeung-Chul Mun - Ewha Womans UniversityYong Park - Korea UniversityYoung Rok Do - Keimyung UniversitySeong Hyun Jeong - Ajou UniversityJoon Seong Park - Ajou UniversitySung Yong Oh - Dong-A UniversitySuee Lee - Dong-A UniversityEun Kyung Park - Chung-Ang University HospitalJoung-Soon Jang - Chung-Ang University HospitalWon-Sik Lee - Inje University Busan Paik HospitalHwe-Won Lee - National Cancer CenterHyeonSeok Eom - Chonnam National University Hwasun HospitalJae-sook Ahn - Chonnam National University Hwasun HospitalJae-Heon Jeong - Chonnam National University Hwasun HospitalSun Kyung Baek - Kyung Hee University Medical CenterSeok Jin Kim - Samsung Medical CenterWon Seog Kim - Samsung Medical CenterCheolwon Suh - University of Ulsan
- Publication Details
- Journal of hematology and oncology, Vol.5(1), pp.49-49
- Publisher
- BioMed Central
- Identifiers
- 9945555308331
- Academic Unit
- King Abdullah University of Science & Technology
- Language
- English
- Resource Type
- Journal article
Journal article
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
Journal of hematology and oncology, Vol.5(1), pp.49-49
13/08/2012
PMCID: PMC3445827
PMID: 22889180
Metrics
1 Record Views